| Serial Number | 88861759 |
| Word Mark | SHORLA PHARMA |
| Filing Date | Monday, April 6, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 26, 2021 |
| Registration Number | 6533302 |
| Registration Date | Tuesday, October 26, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 10, 2021 |
| Disclaimer with Predetermined Text | "PHARMA" |
| Goods and Services | pharmaceutical and medicinal preparations and substances for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical preparations and substances for human use for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical preparations and substances for the prevention and treatment of cancer; pharmaceutical compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of tumors; anti-cancer drugs and pharmaceutical preparations |
| Goods and Services | research and development services in the field of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; biological research; scientific research services; research and development services in the pharmaceutical and biotechnology fields; research services relating to the development and testing of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical product evaluation; testing and inspection of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceutical products; product safety and quality testing in the pharmaceutical and biotechnology fields; provision of information and data relating to research and development in the pharmaceutical and biotechnology fields |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 14, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 14, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Shorla Pharma Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Clonmel, Co. Tipperary E91V239 IE |
| Party Name | Shorla Pharma Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Clonmel, Co. Tipperary E91V239 IE |
| Party Name | Shorla Pharma Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Clonmel, Co. Tipperary E91V239 IE |
| Event Date | Event Description |
| Tuesday, October 26, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 10, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 10, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 21, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, July 1, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 9, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 7, 2021 | ASSIGNED TO LIE |
| Friday, March 12, 2021 | NOTICE OF REVIVAL - E-MAILED |
| Thursday, March 11, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, March 11, 2021 | PETITION TO REVIVE-GRANTED |
| Thursday, March 11, 2021 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, January 11, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Monday, January 11, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, June 29, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 29, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, June 29, 2020 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 24, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, April 14, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, April 9, 2020 | NEW APPLICATION ENTERED IN TRAM |